Evidence map›Paper›PMID 25688742›Full record

ArticleBritish journal of cancer2015

Mammography screening in three Finnish residential areas: comprehensive population-based study of breast cancer incidence and incidence-based mortality 1976-2009.

I Parvinen, S Heinävaara, A Anttila, H Helenius, P Klemi, L Pylkkänen

Abstract read
In one paragraph

Article in British journal of cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

I ParvinenUniversity of Turku, Medical Faculty, University of Turku, FI-20014 Turku, Finland.
S HeinävaaraFinnish Cancer Registry, Unioninkatu 22, FI-00130 Helsinki, Finland.
A AnttilaFinnish Cancer Registry, Unioninkatu 22, FI-00130 Helsinki, Finland.
H HeleniusUniversity of Turku, Medical Faculty, Department of Biostatistics, University of Turku, FI-20014 Turku, Finland.
P KlemiUniversity of Turku, Medical Faculty, Department of Pathology, University of Turku, FI-20014 Turku, Finland.
L Pylkkänen1] University of Turku, Medical Faculty, Department of Clinical Oncology, University of Turku, FI-20014 Turku, Finland [2] Cancer Society of Finland, Unioninkatu 22, FI-00130 Helsinki, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this study was to evaluate the effectiveness of a large-scale screening programme for breast cancer (BC) in Turku, Finland. Incidence and incidence-based mortality (IBM) figures were compared with the areas applying different screening policies.

methodsDeaths and person-time of women aged 40-84 were assessed for the period 1976-1986 (prescreening era) and the periods 1987-1997 and 1998-2009 (screening periods) using incidence and IBM by age at diagnosis and at death. There was a total of 40.7 million women-years, 83 497 invasive BCs obtained from the Finnish Cancer Registry; 17 508 BC deaths were linked with the data from Statistics Finland.

resultsIn Turku, a significant (> 20%) reduction in IBM occurred during 1987-2009 among women aged 60-74 years at diagnosis compared with Helsinki (IBMRR: 0.75, 95% CI: 0.57-1.00), and in women aged 75-84 years at death compared with the rest of Finland (IBMRR: 0.72, 95% CI: 0.53-0.96).

conclusionsThe wide mammography screening programme in Turku was effective in decreasing BC mortality in the elderly age groups. These results support the implementation of BC screening from age 50 up to 74 years.

Indexed as

AdultAgedAged, 80 and overBreast NeoplasmsEarly Detection of CancerFemaleFinlandHumansMammographyMass ScreeningMiddle AgedSurvival AnalysisUrban Population

Identifiers

PMID25688742
PMCPMC4453946

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.